Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells - PubMed (original) (raw)
. 2002 Apr 15;99(8):2767-75.
doi: 10.1182/blood.v99.8.2767.
Affiliations
- PMID: 11929765
- DOI: 10.1182/blood.v99.8.2767
Free article
Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells
Enrique Samper et al. Blood. 2002.
Free article
Abstract
Telomere length must be tightly regulated in highly proliferative tissues, such as the lymphohematopoietic system. Under steady-state conditions, the levels and functionality of hematopoietic-committed or multipotent progenitors were not affected in late-generation telomerase-deficient mice (mTerc(-/-)) with critically short telomeres. Evaluation of self-renewal potential of mTerc(-/-) day-12 spleen colony-forming units demonstrated no alteration as compared with wildtype progenitors. However, the replating ability of mTerc(-/-) granulocyte-macrophage CFUs (CFU-GMs) was greatly reduced as compared with wildtype CFU-GMs, indicating a diminished capacity of late-generation mTerc(-/-) committed progenitors when forced to proliferate. Long-term bone marrow cultures of mTerc(-/-) bone marrow (BM) cells show a reduction in proliferative capacity; this defect can be mainly attributed to the hematopoietic, not to the stromal, mTerc(-/-) cells. In serial and competitive transplantations, mTerc(-/-) BM stem cells show reduced long-term repopulating capacity, concomitant with an increase in genetic instability compared with wildtype cells. Nevertheless, in competitive transplantations late-generation mTerc(-/-) precursors can occasionally overcome this proliferative impairment and reconstitute irradiated recipients. In summary, our results demonstrate that late-generation mTerc(-/-) BM cells with short telomeres, although exhibiting reduced proliferation ability and reduced long-term repopulating capacity, can still reconstitute myeloablated animals maintaining stem cell function.
Similar articles
- Interleukin-6 deficiency affects bone marrow stromal precursors, resulting in defective hematopoietic support.
Rodríguez Mdel C, Bernad A, Aracil M. Rodríguez Mdel C, et al. Blood. 2004 May 1;103(9):3349-54. doi: 10.1182/blood-2003-10-3438. Epub 2003 Dec 30. Blood. 2004. PMID: 14701687 - Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells.
Szilvassy SJ, Weller KP, Lin W, Sharma AK, Ho AS, Tsukamoto A, Hoffman R, Leiby KR, Gearing DP. Szilvassy SJ, et al. Blood. 1996 Jun 1;87(11):4618-28. Blood. 1996. PMID: 8639830 - Segregation and characterization of lymphohematopoietic stromal elements.
Crouse DA, Mann SL, Sharp JG. Crouse DA, et al. Kroc Found Ser. 1984;18:211-31. Kroc Found Ser. 1984. PMID: 6397572 Review. - Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays.
Coulombel L. Coulombel L. Oncogene. 2004 Sep 20;23(43):7210-22. doi: 10.1038/sj.onc.1207941. Oncogene. 2004. PMID: 15378081 Review.
Cited by
- Boosting NAD ameliorates hematopoietic impairment linked to short telomeres in vivo.
Stock AJ, Ayyar S, Kashyap A, Wang Y, Yanai H, Starost MF, Tanaka-Yano M, Bodogai M, Sun C, Wang Y, Gong Y, Puligilla C, Fang EF, Bohr VA, Liu Y, Beerman I. Stock AJ, et al. Geroscience. 2023 Aug;45(4):2213-2228. doi: 10.1007/s11357-023-00752-2. Epub 2023 Feb 24. Geroscience. 2023. PMID: 36826621 Free PMC article. - Differential impact of a dyskeratosis congenita mutation in TPP1 on mouse hematopoiesis and germline.
Graniel JV, Bisht K, Friedman A, White J, Perkey E, Vanderbeck A, Moroz A, Carrington LJ, Brandstadter JD, Allen F, Shami AN, Thomas P, Crayton A, Manzor M, Mychalowych A, Chase J, Hammoud SS, Keegan CE, Maillard I, Nandakumar J. Graniel JV, et al. Life Sci Alliance. 2021 Oct 13;5(1):e202101208. doi: 10.26508/lsa.202101208. Print 2022 Jan. Life Sci Alliance. 2021. PMID: 34645668 Free PMC article. - Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.
Myllymäki M, Redd R, Reilly CR, Saber W, Spellman SR, Gibson CJ, Hu ZH, Wang T, Orr EH, Grenier JG, Chen MM, Steensma DP, Cutler C, De Vivo I, Antin JH, Neuberg D, Agarwal S, Lindsley RC. Myllymäki M, et al. Blood. 2020 Dec 24;136(26):3070-3081. doi: 10.1182/blood.2020005397. Blood. 2020. PMID: 33367544 Free PMC article. Clinical Trial. - Proliferation: Driver of HSC aging phenotypes?
Yanai H, Beerman I. Yanai H, et al. Mech Ageing Dev. 2020 Oct;191:111331. doi: 10.1016/j.mad.2020.111331. Epub 2020 Aug 14. Mech Ageing Dev. 2020. PMID: 32798509 Free PMC article. Review. - Clonal hematopoiesis in the inherited bone marrow failure syndromes.
Tsai FD, Lindsley RC. Tsai FD, et al. Blood. 2020 Oct 1;136(14):1615-1622. doi: 10.1182/blood.2019000990. Blood. 2020. PMID: 32736377 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical